Does PEMBROLIZUMAB Cause Haemoglobin decreased? 336 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 336 reports of Haemoglobin decreased have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.4% of all adverse event reports for PEMBROLIZUMAB.
336
Reports of Haemoglobin decreased with PEMBROLIZUMAB
0.4%
of all PEMBROLIZUMAB reports
48
Deaths
158
Hospitalizations
How Dangerous Is Haemoglobin decreased From PEMBROLIZUMAB?
Of the 336 reports, 48 (14.3%) resulted in death, 158 (47.0%) required hospitalization, and 41 (12.2%) were considered life-threatening.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEMBROLIZUMAB. However, 336 reports have been filed with the FAERS database.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which PEMBROLIZUMAB Alternatives Have Lower Haemoglobin decreased Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G